SUVEN PHARMACEUTICALS LTD.
Quaterly Results
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Audited / UnAudited | UnAudited | UnAudited | UnAudited | Audited |
Net Sales | 2198.2 | 2310.54 | 3475.5 | 3693.56 |
Total Expenditure | 1546.75 | 1330.92 | 1805.84 | 2002.78 |
PBIDT (Excl OI) | 651.45 | 979.62 | 1669.66 | 1690.78 |
Other Income | 143.45 | 198.42 | 106.65 | 114 |
Operating Profit | 794.89 | 1178.03 | 1776.31 | 1804.78 |
Interest | 12.69 | 5.03 | 11.47 | 23.09 |
Exceptional Items | NA | NA | NA | NA |
PBDT | 782.2 | 1173 | 1764.84 | 1781.69 |
Depreciation | 127.52 | 118.92 | 125.41 | 119.58 |
Profit Before Tax | 654.68 | 1054.08 | 1639.43 | 1662.11 |
Tax | 187.15 | 258.45 | 433.53 | 422.4 |
Provisions and contingencies | NA | NA | NA | NA |
Profit After Tax | 467.53 | 795.63 | 1205.9 | 1239.71 |
Extraordinary Items | NA | NA | NA | NA |
Prior Period Expenses | NA | NA | NA | NA |
Other Adjustments | NA | NA | NA | NA |
Net Profit | 467.53 | 795.63 | 1205.9 | 1239.71 |
Minority Interest | NA | NA | NA | NA |
Shares of Associates | ||||
Other related items | ||||
Misc. Expenses Written off | NA | NA | NA | NA |
Consolidated Net Profit | 467.54 | 795.64 | 1205.9 | 1239.71 |
Equity Capital | 254.57 | 254.57 | 254.57 | 254.57 |
Face Value (IN RS) | 1 | 1 | 1 | 1 |
Reserves | NA | NA | NA | NA |
Calculated EPS | 1.83 | 3.12 | 4.73 | 4.86 |
Calculated EPS (Annualised) | 7.34 | 12.50 | 18.94 | 19.47 |
No of Public Share Holdings | 101822407 | 101824956 | 101824956 | 101824956 |
% of Public Share Holdings | 40 | 40 | 40 | 40 |
| NA | NA | NA | NA |
PBIDTM% (Excl OI) | 29.63 | 42.39 | 48.04 | 45.77 |
PBIDTM% | 36.16 | 50.98 | 51.10 | 48.86 |
PBDTM% | 35.58 | 50.76 | 50.77 | 48.23 |
PBTM% | 29.78 | 45.62 | 47.17 | 45.00 |
PATM% | 21.26 | 34.43 | 34.69 | 33.56 |
"; | Notes | Notes | Notes | Notes |